Back to Evidence
Primary experimental recordPositive observation

PMC13231543::ACT047723

sP10

Evidence text

Paper-level observation

Our findings revealed that P10 and sP10 inhibited the proliferation of SK-Hep1 cells and Hepa1-6 cells, respectively, as demonstrated by the CCK-8 proliferation assay (Fig. 3A).
figureConfidence: medium

Assay observation

Activity
Anticancer
Subtype
Cytotoxic
Measure
cell_viability
Comparator
range
Raw observation
inhibited proliferation
Normalized measurement
1–6
Value minimum
1
Value maximum
6
Target
SK-Hep1
Assay method
Not reported by source
Sequence
YGRKKRRQRRRCGPVWFLIFSYFLFFSISLARGPC
Standardization
ready simple

Source publication

Peptide aptamer sP10 targeting NPM1 attenuates liver fibrosis and hepatocellular carcinoma.

Journal of Translational Medicine · 2026

Related peptide identities

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.